An increase in protocol complexity is paving the way for machine learning models to optimize trial design.
Aleksa Jovanovic MD, PhD
Advertisement
Scientific Engagement and Innovation Specialist, Wemedoo AG
Articles by Aleksa Jovanovic MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Comparing OpenAI and Mistral on Clinical Trial Matching
2
Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
3
Why Outdated Perceptions of APAC Clinical Trial Sites Persist Among Smaller Biotechs
4
From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA
5